Madhura Kelkar - Publications

2017-2021 National Institute of Immunohaematology (ICMR), Mumbai 

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rathod M, Kelkar M, Valvi S, Salve G, De A. FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy. Molecular Therapy Oncolytics. 19: 93-104. PMID 33102692 DOI: 10.1016/J.Omto.2020.08.015  0.675
2018 Rathod M, Kelkar M, Salvi G, De A. PO-022 Benzamide class of HDACi differentially enhance sodium iodide symporter expression in breast cancer Esmo Open. 3: A236. DOI: 10.1136/esmoopen-2018-EACR25.557  0.658
2018 Agrawal S, Kelkar M, De A, Kulkarni AR, Gandhi MN. Newly emerging mesoporous strontium hydroxyapatite nanorods: microwave synthesis and relevance as doxorubicin nanocarrier Journal of Nanoparticle Research. 20: 230. DOI: 10.1007/S11051-018-4335-Y  0.511
2017 Kelkar MG, Thakur B, Derle A, Chatterjee S, Ray P, De A. Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer. Breast Cancer Research and Treatment. PMID 28528452 DOI: 10.1007/s10549-017-4297-2  0.598
2016 Kelkar MG, Senthilkumar K, Jadhav S, Gupta S, Ahn BC, De A. Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation. Scientific Reports. 6: 19341. PMID 26777440 DOI: 10.1038/Srep19341  0.683
2016 Agrawal S, Kelkar M, De A, Kulkarni AR, Gandhi MN. Surfactant free novel one-minute microwave synthesis, characterization and cell toxicity study of mesoporous strontium hydroxyapatite nanorods Rsc Advances. 6: 94921-94926. DOI: 10.1039/C6Ra21708G  0.493
2012 Srivastava M, Nambiar M, Sharma S, Karki SS, Goldsmith G, Hegde M, Kumar S, Pandey M, Singh RK, Ray P, Natarajan R, Kelkar M, De A, Choudhary B, Raghavan SC. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell. 151: 1474-87. PMID 23260137 DOI: 10.1016/J.Cell.2012.11.054  0.553
2012 Kelkar M, De A. Bioluminescence based in vivo screening technologies. Current Opinion in Pharmacology. 12: 592-600. PMID 22954534 DOI: 10.1016/J.Coph.2012.07.014  0.501
Show low-probability matches.